{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:07:18Z","timestamp":1778972838504,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030692","name":"National Institute on Drug Abuse Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.josat.2026.209924","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:58:01Z","timestamp":1772672281000},"page":"209924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020"],"prefix":"10.1016","volume":"187","author":[{"given":"Julie M.","family":"Donohue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan S.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Chou H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Deanna","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utibe R.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Hammerslag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Talbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Idala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamis","family":"Mohamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orrin","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystel","family":"Tossone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2026.209924_bb0005","first-page":"22","article-title":"Disparities in treatment for substance use disorders and co-occurring disorders for ethnic\/racial minority youth","volume":"50","author":"Alegria","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.josat.2026.209924_bb0010","author":"Barnes"},{"issue":"19","key":"10.1016\/j.josat.2026.209924_bb0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.209924_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MLR.0000000000001838","article-title":"Measurement approaches to estimating methadone continuity in opioid use disorder care","volume":"61","author":"Busch","year":"2023","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.josat.2026.209924_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21556660.2020.1750419","article-title":"Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: Development and evaluation of an algorithm for use in EHR and claims data","volume":"9","author":"Carrell","year":"2020","journal-title":"Journal of Drug Assessment"},{"key":"10.1016\/j.josat.2026.209924_bb0205","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2026.209924_bb0030","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2026.209924_bb0225","author":"Centers for Medicare and Medicaid Services"},{"issue":"10","key":"10.1016\/j.josat.2026.209924_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.3549","article-title":"Removal of Medicaid prior authorization requirements and buprenorphine treatment for opioid use disorder","volume":"4","author":"Christine","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2026.209924_bb0040","author":"Corrallo"},{"key":"10.1016\/j.josat.2026.209924_bb0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11524-020-00439-5","article-title":"Racial disparities in overdose prevention among people who inject drugs","volume":"97","author":"Dayton","year":"2020","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.josat.2026.209924_bb0050","author":"Donohue"},{"issue":"11","key":"10.1016\/j.josat.2026.209924_bb0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2022.14791","article-title":"The US Medicaid program: Coverage, financing, reforms, and implications for health equity","volume":"328","author":"Donohue","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2026.209924_bb0060","author":"DQ Atlas: Race and Ethnicity"},{"issue":"5","key":"10.1016\/j.josat.2026.209924_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2013ethnic disparities of buprenorphine and vivitrol receipt in Medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2026.209924_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108589","article-title":"The intersection of race and opioid use disorder treatment: A quantitative analysis","volume":"131","author":"Entress","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2026.209924_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2026.209924_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/haschl\/qxae049","article-title":"Piloting racial bias training for hospital emergency department providers treating opioid use disorder patients","author":"Gibbons","year":"2024","journal-title":"Health Affairs Scholar"},{"issue":"4","key":"10.1016\/j.josat.2026.209924_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1016\/j.josat.2026.209924_bb0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pds.4772","article-title":"Identifying and classifying opioid-related overdoses: A validation study","volume":"28","author":"Green","year":"2019","journal-title":"Pharmacoepidemiology & Drug Safety"},{"key":"10.1016\/j.josat.2026.209924_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107296","article-title":"A bifurcated opioid treatment systems and widening insidious disparities","volume":"130","author":"Guerrero","year":"2022","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2026.209924_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jsat.2019.07.009","article-title":"Drivers of continued implementation of cultural competence in substance use disorder treatment","volume":"105","author":"Guerrero","year":"2019","journal-title":"Journal of Substance Abuse Treament"},{"issue":"12","key":"10.1016\/j.josat.2026.209924_bb0105","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","article-title":"Is the prescription opioid epidemic a white problem?","volume":"106","author":"Hansen","year":"2016","journal-title":"American Journal of Public Health"},{"issue":"5","key":"10.1016\/j.josat.2026.209924_bb0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/0162243920912812","article-title":"Race as a ghost variable in (white) opioid research","volume":"45","author":"Hansen","year":"2020","journal-title":"Science, Technology, & Human Values"},{"issue":"3","key":"10.1016\/j.josat.2026.209924_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"Journal of Behavioral Health Services & Research"},{"issue":"5","key":"10.1016\/j.josat.2026.209924_bb0125","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder diagnoses in administrative data: A chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.209924_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1016\/j.josat.2026.209924_bb0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073110518782949","article-title":"The opioid crisis in black communities","volume":"46","author":"James","year":"2018","journal-title":"The Journal of Law, Medicine & Ethics"},{"key":"10.1016\/j.josat.2026.209924_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2025.209814","article-title":"Developing and validating measures of take-home methadone wiht administrative data","volume":"180","author":"Kapadia","year":"2026","journal-title":"Journal of Substance Use & Addiction Treatment"},{"key":"10.1016\/j.josat.2026.209924_bb0150","author":"Kennedy"},{"key":"10.1016\/j.josat.2026.209924_bb0155","author":"KFF"},{"issue":"3","key":"10.1016\/j.josat.2026.209924_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PHH.0000000000001168","article-title":"Structural racism and the opioid overdose epidemic: The need for antiracist public health practice","volume":"26","author":"Kunins","year":"2020","journal-title":"Journal of Public Health Management and Practice"},{"issue":"43","key":"10.1016\/j.josat.2026.209924_bb0165","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","article-title":"Racial\/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged \u226518 years in metropolitan areas\u2014United States, 2015\u20132017","volume":"68","author":"Lippold","year":"2019","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.josat.2026.209924_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2021.7374","article-title":"Use of medications for treatment of opioid use disorder among US Medicaid enrollees in 11 states, 2014\u20132018","volume":"326","author":"Medicaid Outcomes Distributed Research Network (MODRN)","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.josat.2026.209924_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/17445647.2023.2270632","article-title":"Race, rurality, and geographic accessibiltiy to medication for opioid use disorder in the US","volume":"19","author":"Mitchell","year":"2023","journal-title":"Journal of Maps"},{"issue":"1","key":"10.1016\/j.josat.2026.209924_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08897077.2020.1866144","article-title":"Confronting COVID, racism, and addiction: The association of multidisciplinary education and research in substance use and addiction (AMERSA)","volume":"42","author":"Mountain-Ray","year":"2021","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2026.209924_bb0185","author":"NAACP"},{"key":"10.1016\/j.josat.2026.209924_bb0190","series-title":"Medications for opioid use disorder save lives","article-title":"National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Medication-Assisted Treatment for Opioid Use Disorder","year":"2019"},{"issue":"6","key":"10.1016\/j.josat.2026.209924_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.14765","article-title":"Racial and ethnic disparities in buprenorphine and extended-release naltrexone filled prescriptions during the COVID-19 pandemic","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.209924_bb0120","series-title":"Statistical Policy Directive No. 15 on Race and Ethnicity Data Standards","author":"Office of Management and Budget","year":"2024"},{"key":"10.1016\/j.josat.2026.209924_bb0200","author":"Orgera"},{"key":"10.1016\/j.josat.2026.209924_bb0210","series-title":"flexible imputation of missing data","author":"Rubin","year":"2018"},{"issue":"5152","key":"10.1016\/j.josat.2026.209924_bb0215","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"108710","key":"10.1016\/j.josat.2026.209924_bb0220","article-title":"Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007\u20132017","volume":"223","author":"Schuler","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209924_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108328","article-title":"Operationalizing and selecting outcome measures for the HEALing Communities Study","volume":"217","author":"Slavova","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209924_bb0235","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2026.209924_bb4000","series-title":"Medications for the Treatment of Opioid Use Disorder","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2024"},{"key":"10.1016\/j.josat.2026.209924_bb0240","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/MLR.0b013e31829b1bb1","article-title":"Confounding adjustment in comparative effectiveness research conducted within distributed research networks","volume":"51","author":"Toh","year":"2013","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.209924_bb0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MLR.0000000000000147","article-title":"Privacy-preserving analytic methods for multisite comparative effectiveness and patient-centered outcomes research","volume":"52","author":"Toh","year":"2014","journal-title":"Medical Care"},{"issue":"9","key":"10.1016\/j.josat.2026.209924_bb0250","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MLR.0000000000001751","article-title":"Design, implementation, and evolution of the Medicaid Outcomes Distributed Research Network (MODRN)","volume":"60","author":"Zivin","year":"2022","journal-title":"Medical Care"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:27:52Z","timestamp":1778970472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S2949875926000445"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209924","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209924"}}